BlackRock »

Gain Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2023-09-30 $92k 28k 3.28
2023-06-30 $130k 29k 4.48
2023-03-31 $119k 25k 4.82
2022-12-31 $78k 25k 3.13
2022-06-30 $86k 24k 3.66
2021-06-30 $115k 12k 9.85